1
Gene Transfer for SCID-X1 Using a Self-inactivating Lentiviral Vector （TYF-IL-2Rg）
Condition(s):SCID, X LinkedLast Updated:September 19, 2019Recruiting
SCID-X1: 8 Clinical Trials
Hide Studies Not Open or Pending
2
Gene Therapy for X-linked Severe Combined Immunodeficiency (SCID-X1)
Condition(s):X-linked Severe Combined ImmunodeficiencyLast Updated:August 1, 2017Unknown status
3
Gene Transfer for Severe Combined Immunodeficiency, X-linked (SCID-X1) Using a Self-inactivating (SIN) Gammaretroviral Vector
Condition(s):Severe Combined ImmunodeficiencyLast Updated:April 19, 2021Active, not recruiting
4
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Condition(s):Severe Combined Immunodeficiency, X Linked; Gene TherapyLast Updated:April 19, 2021Recruiting
5
Gene Therapy for X-linked Severe Combined Immunodeficiency
Condition(s):X-linked Severe Combined ImmunodeficiencyLast Updated:August 26, 2016Unknown status
6
Lentiviral Gene Therapy for X-linked Severe Combined Immunodeficiency
Condition(s):Severe Combined Immunodeficiency, X-LinkedLast Updated:February 11, 2021Recruiting
7
Gene Transfer for X-Linked Severe Combined Immunodeficiency in Newly Diagnosed Infants
Condition(s):Severe Combined Immunodeficiency Disease, X-linkedLast Updated:December 21, 2020Recruiting
8
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
Condition(s):X-Linked Severe Combined Immune Deficiency (XSCID)Last Updated:April 22, 2021Recruiting